Vitality Watch

Dossier pubmed trial late 25-sep-2026
Large or late-phase randomized human trial

Study on blueberries, protein and exercise for improving frailty and cardiovascular disease (STRONG): protocol for a parallel-group randomised controlled superiority trial in older Nova Scotians.

Key claim: The STRONG trial will test whether one year of daily blueberries, 30 g protein powder, and thrice-weekly multimodal exercise reduces frailty and improves cardiovascular health versus usual care in adults aged 65+.

Abstract

INTRODUCTION: As frailty and cardiovascular disease are closely linked, lifestyle interventions to reduce frailty could improve cardiovascular health in at-risk individuals. Previous clinical trials have shown that exercise reduces frailty, both individually and in combination with dietary protein. Blueberries can improve vascular health and protect against cellular senescence. The objective of the study on blueberries, protein and exercise for improving frailty and cardiovascular disease (STRONG) is to determine whether a year-long treatment including blueberries, protein and exercise will reduce frailty and improve cardiovascular health in older adults of both sexes. METHODS AND ANALYSIS: STRONG is a pragmatic randomised controlled trial 1 year in length with an additional year of follow-up. We will recruit 240 adults aged ≥65 years (120 females and 120 males) in Nova Scotia, Canada. Participants will be randomly assigned to the STRONG intervention group (1 cup of blueberries/day, 30 g of protein powder/day and three 60-min multimodal exercise sessions with an exercise physiologist/week) or the control group (usual care). Measured outcomes will include changes in frailty (eg, frailty scores, balance, falls, changes in life-space, social engagement), cardiovascular disease risk factors (eg, blood pressure, lipid profile, Framingham risk score), cardiovascular health (eg, 6-min walk test, cardiac function measures), inflammatory markers, physical fitness, diet quality and health-related quality of life. All measures will be collected at baseline and 12 months, with many also repeated at the 3-, 6-, 9- and 24-month time points. ETHICS AND DISSEMINATION: This study has received approval from the Nova Scotia Health Research Ethics Board (ROMEO #1031656) and is being conducted according to Consolidated Standards of Reporting Trials (CONSORT) and Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) guidelines. The findings will be disseminated through peer-reviewed publications, academic and community presentations, lay materials on our research team websites and social media and summaries/briefings to stakeholders that will be directed toward registered dietitians, exercise physiologists and clinicians. TRIAL REGISTRATION NUMBER: NCT06693271.

Why this matters

STRONG is one of the few sizable year-long RCTs designed to test whether stacking a supervised multimodal exercise program with two well-studied nutritional co-interventions (protein powder and blueberries) moves both frailty and cardiovascular endpoints together in adults 65+. Because each component already has independent human evidence, the trial’s value will hinge on whether the combined package outperforms usual care on hard functional endpoints — a question current single-component trials cannot answer. Until readout, it is a design signal, not evidence.

Source

Link

Briefing card

Study on blueberries, protein and exercise for improving frailty and cardiovascular disease (STRONG): protocol for a parallel-group randomised controlled superiority trial in older Nova Scotians.
Stage: trial late · pubmed · 25-sep-2026

If you are 65+ in Nova Scotia and enrolled in STRONG, you will receive a year of daily blueberries, 30 g protein powder, and thrice-weekly supervised exercise — but efficacy results are not yet available.

The STRONG trial will test whether one year of daily blueberries, 30 g protein powder, and thrice-weekly multimodal exercise reduces frailty and improves cardiovascular health versus usual care in adults aged 65+.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1136/bmjopen-2025-114286

build build 880 · 2bcef25 · 2026-11-18